May 6, 2020 / 12:34 PM / 20 days ago

BRIEF-Trovagene Announces Changing Of Company Name To Cardiff Oncology And Appointment Of Mark Erlander As CEO

May 6 (Reuters) - Trovagene Inc:

* TROVAGENE ANNOUNCES CHANGING OF COMPANY NAME TO CARDIFF ONCOLOGY AND APPOINTMENT OF MARK ERLANDER, PHD, AS CHIEF EXECUTIVE OFFICER

* TROVAGENE INC - CHANGING ITS COMPANY NAME TO CARDIFF ONCOLOGY INC

* TROVAGENE - MARK ERLANDER WILL ASSUME ROLE OF CEO OF CARDIFF ONCOLOGY

* TROVAGENE INC - NASDAQ TICKER SYMBOL WILL CHANGE TO ‘CRDF’ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below